[HTML][HTML] Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS …, 2021 - journals.plos.org
Background/Aims Non-alcoholic fatty liver disease (NAFLD) represents a significant public
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS …, 2021 - discovery.ucl.ac.uk
BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) represents a significant
public health issue. Identifying patients with simple steatosis from those with non-alcoholic …
public health issue. Identifying patients with simple steatosis from those with non-alcoholic …
[HTML][HTML] Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS ONE, 2021 - ncbi.nlm.nih.gov
Methods This prospective, cross-sectional study included 105 adult patients with varying
severity of NAFLD. Twelve serum-based markers were measured by 3 biochip platforms and …
severity of NAFLD. Twelve serum-based markers were measured by 3 biochip platforms and …
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
A Goyale, A Jain, C Smith, M Papatheodoridi… - Plos one, 2021 - europepmc.org
Methods This prospective, cross-sectional study included 105 adult patients with varying
severity of NAFLD. Twelve serum-based markers were measured by 3 biochip platforms and …
severity of NAFLD. Twelve serum-based markers were measured by 3 biochip platforms and …
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS …, 2021 - search.ebscohost.com
Abstract Background/Aims: Non-alcoholic fatty liver disease (NAFLD) represents a
significant public health issue. Identifying patients with simple steatosis from those with non …
significant public health issue. Identifying patients with simple steatosis from those with non …
[PDF][PDF] Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS …, 2021 - pdfs.semanticscholar.org
Background/Aims Non-alcoholic fatty liver disease (NAFLD) represents a significant public
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
A Goyale, A Jain, C Smith, M Papatheodoridi… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Background/aims Non-alcoholic fatty liver disease (NAFLD) represents a significant public
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
[引用][C] Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study
A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS …, 2021 - ui.adsabs.harvard.edu
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based
markers: A pilot study - NASA/ADS Now on home page ads icon ads Enable full ADS view …
markers: A pilot study - NASA/ADS Now on home page ads icon ads Enable full ADS view …
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS ONE, 2021 - go.gale.com
Background/Aims Non-alcoholic fatty liver disease (NAFLD) represents a significant public
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
health issue. Identifying patients with simple steatosis from those with non-alcoholic …
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
A Goyale, A Jain, C Smith, M Papatheodoridi… - Plos one, 2021 - europepmc.org
Methods This prospective, cross-sectional study included 105 adult patients with varying
severity of NAFLD. Twelve serum-based markers were measured by 3 biochip platforms and …
severity of NAFLD. Twelve serum-based markers were measured by 3 biochip platforms and …